Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 5 studies | 27% ± 7% | |
| astrocyte | 5 studies | 26% ± 6% | |
| neuron | 4 studies | 29% ± 7% | |
| epithelial cell | 4 studies | 19% ± 1% | |
| oligodendrocyte | 4 studies | 23% ± 3% | |
| microglial cell | 3 studies | 22% ± 1% | |
| retinal rod cell | 3 studies | 16% ± 0% | |
| dendritic cell | 3 studies | 24% ± 11% | |
| macrophage | 3 studies | 20% ± 1% | |
| GABAergic neuron | 3 studies | 39% ± 13% | |
| glutamatergic neuron | 3 studies | 46% ± 15% | |
| interneuron | 3 studies | 40% ± 19% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 5 studies | 30% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 1153.99 | 1445 / 1445 | 100% | 9.42 | 183 / 183 |
| brain | 100% | 2218.63 | 2641 / 2642 | 100% | 16.29 | 705 / 705 |
| thymus | 100% | 1197.18 | 652 / 653 | 99% | 6.10 | 598 / 605 |
| prostate | 100% | 1254.17 | 245 / 245 | 99% | 7.12 | 495 / 502 |
| breast | 100% | 1148.65 | 459 / 459 | 98% | 7.10 | 1092 / 1118 |
| kidney | 100% | 853.09 | 89 / 89 | 97% | 6.36 | 871 / 901 |
| lung | 99% | 1107.19 | 575 / 578 | 96% | 5.12 | 1111 / 1155 |
| pancreas | 98% | 566.11 | 323 / 328 | 97% | 5.34 | 172 / 178 |
| adrenal gland | 100% | 889.22 | 258 / 258 | 95% | 9.04 | 218 / 230 |
| uterus | 100% | 1393.41 | 170 / 170 | 94% | 5.28 | 430 / 459 |
| skin | 100% | 1111.07 | 1806 / 1809 | 91% | 6.25 | 428 / 472 |
| bladder | 100% | 1305.48 | 21 / 21 | 88% | 3.95 | 442 / 504 |
| stomach | 100% | 856.02 | 358 / 359 | 87% | 5.10 | 250 / 286 |
| intestine | 100% | 1756.45 | 966 / 966 | 80% | 3.74 | 419 / 527 |
| ovary | 100% | 1094.43 | 180 / 180 | 76% | 2.81 | 326 / 430 |
| liver | 99% | 506.82 | 223 / 226 | 37% | 1.31 | 151 / 406 |
| adipose | 100% | 1298.66 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 1288.41 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 100% | 1131.74 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 1107.07 | 241 / 241 | 0% | 0 | 0 / 0 |
| heart | 99% | 1136.95 | 849 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 5.39 | 44 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 93% | 4.52 | 27 / 29 |
| eye | 0% | 0 | 0 / 0 | 65% | 2.55 | 52 / 80 |
| peripheral blood | 61% | 548.63 | 569 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0010507 | Biological process | negative regulation of autophagy |
| GO_0060304 | Biological process | regulation of phosphatidylinositol dephosphorylation |
| GO_0010922 | Biological process | positive regulation of phosphatase activity |
| GO_0046856 | Biological process | phosphatidylinositol dephosphorylation |
| GO_0006897 | Biological process | endocytosis |
| GO_0050821 | Biological process | protein stabilization |
| GO_0032587 | Cellular component | ruffle membrane |
| GO_0032991 | Cellular component | protein-containing complex |
| GO_0005783 | Cellular component | endoplasmic reticulum |
| GO_0005829 | Cellular component | cytosol |
| GO_0048471 | Cellular component | perinuclear region of cytoplasm |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0030234 | Molecular function | enzyme regulator activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0019903 | Molecular function | protein phosphatase binding |
| Gene name | MTMR9 |
| Protein name | Myotubularin-related protein 9 (Inactive phosphatidylinositol 3-phosphatase 9) Myotubularin related protein 9 |
| Synonyms | MTMR8 C8orf9 |
| Description | FUNCTION: Acts as an adapter for myotubularin-related phosphatases . Increases lipid phosphatase MTMR6 catalytic activity, specifically towards phosphatidylinositol 3,5-bisphosphate and MTMR6 binding affinity for phosphorylated phosphatidylinositols . Positively regulates lipid phosphatase MTMR7 catalytic activity (By similarity). Increases MTMR8 catalytic activity towards phosphatidylinositol 3-phosphate . The formation of the MTMR6-MTMR9 complex, stabilizes both MTMR6 and MTMR9 protein levels . Stabilizes MTMR8 protein levels . Plays a role in the late stages of macropinocytosis possibly by regulating MTMR6-mediated dephosphorylation of phosphatidylinositol 3-phosphate in membrane ruffles . Negatively regulates autophagy, in part via its association with MTMR8 . Negatively regulates DNA damage-induced apoptosis, in part via its association with MTMR6 . Does not bind mono-, di- and tri-phosphorylated phosphatidylinositols, phosphatidic acid and phosphatidylserine . . |
| Accessions | ENST00000646141.3 [Q96QG7-2] ENST00000526292.1 [Q96QG7-2] ENST00000221086.8 [Q96QG7-1] ENST00000530200.1 Q96QG7 E9PR67 ENST00000644306.3 [Q96QG7-1] |